ARAMARK Healthcare announces its partnership with Tru-D SmartUVC™ technology, a cutting-edge portable UV disinfection system technology designed to effectively and efficiently help prevent healthcare-associated infections (HAIs) in hospitals across North America. ARAMARK is able to provide a baseline of thorough disinfection with Tru-D's Sensor360™ technology allowing accurate UV dose delivery.
"After extensive research and due diligence, we selected Tru-D for its proven performance, ability to destroy targeted pathogens with repeatable outcomes and consistency in doing so while eliminating human error," says Dave Carpenter, president of ARAMARK Healthcare. "Understanding HAIs implications for our clients, patients and employees, we know infection prevention is a critical component to driving positive outcomes and the prevention of HAI's."
According to the CDC, healthcare-associated infections kill more than 90,000 patients per year in the U.S. and cost $28 billion to the healthcare industry. Tru-D technology is an automated portable disinfection device that generates a consistent dose of UV energy that destroys 99.9 percent of the pathogens associated with HAIs such as C. difficile, MRSA, VRE and norovirus. The instrument automatically adjusts its output to compensate for room variability including size, reflective properties, and equipment contents. The technology offers real-time sensor readings to ensure the correct dosage is achieved every time therefore eliminating human error in the disinfection process.
"There is a tremendous opportunity to help hospitals protect against the spread of HAI's and through our partnership with ARAMARK Healthcare we are able to expand the presence of Tru-D in the healthcare marketplace to combat these issues and achieve tangible results," says Chuck Dunn, president and CEO of Tru-D LLC.